Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Mar 24 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-24-2023-2

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 24, 2023, titled "Zydus receives Final Approval from the USFDA for Lubiprostone Capsules, 8 mcg and 24 mcg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases